Search

everythinglearnresearchcommunity

for

Search:↓

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

Certain bacteria can enhance skin regeneration.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Keratinocyte stem cells are crucial for skin renewal and have potential in wound healing and tissue regeneration.

Extracellular vesicles can help repair and regenerate tissues with less risk of rejection.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

The new biomimetic skin heals wounds faster and better than traditional treatments, without scarring.

PRC2 is not essential for hair follicle stem cell maintenance or hair growth.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

PRP is a promising, cost-effective treatment for hair loss by stimulating hair growth.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

The study created a mouse model to mimic degenerative diseases for testing tissue repair and new therapies.

Injecting lentiviral vectors into early gestation mice effectively targets skin stem cells for potential gene therapy.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Blood count parameters are not reliable for predicting recurrent implantation failure.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

The new method is 1000 times more sensitive for measuring hair growth.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.